drugset / Trial / NCT00933673
New Combination Regimen of L-asparaginase, Dexamethasone, Ifosfamide, Cisplatin and Etoposide in NK/T-Cell Lymphoma
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy and tolerability of the combination chemotherapy of L-asparaginase plus DICE regimen in the patients with early stage NK/T-cell lymphoma.
Timeline
- Start
- 2009-06
- Primary completion
- 2012-06
- Completion
- 2012-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DDP | Unknown | 20 mg/m2 | — |
| Subject | DXM | Unknown | 40 mg | — |
| Subject | Etoposide | Small molecule | 60 mg/m2 | — |
| Subject | IFO | Unknown | 1200 mg/m2 | — |
| Subject | L-asp | Unknown | 6000 unknown | — |
| Background | 2-MERCAPTOETHANESULFONIC ACID | Small molecule | 400 mg | — |